Financial Perspectives’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$83.4K Hold
1,000
– – 0.02% 268
2026
Q2
$66.4K Buy
+1,000
New +$84.6K 0.02% 290
2024
Q1
– Sell
-4,709
Closed -$372K – 701
2023
Q4
$372K Hold
4,709
– – 0.15% 83
2023
Q3
$258K Hold
4,709
– – 0.12% 103
2023
Q2
$395K Hold
4,709
– – 0.17% 75
2023
Q1
$357K Hold
4,709
– – 0.17% 81
2022
Q4
$291K Hold
4,709
– – 0.15% 90
2022
Q3
$197K Hold
4,709
– – 0.11% 120
2022
Q2
$148K Hold
4,709
– – 0.08% 137
2022
Q1
$127K Hold
4,709
– – 0.06% 162
2021
Q4
$90.2K Hold
4,709
– – 0.04% 185
2021
Q3
$156K Buy
4,709
+1,480
+46% +$45.2K 0.08% 137
2021
Q2
$107K Buy
+3,229
New +$89.5K 0.05% 179

Other funds holding TMDX

Financial Perspectives's TMDX Position: Q3 2026 in Review

Financial Perspectives held its Transmedics (TMDX) position steady in Q3 2026 at 1,000 shares worth $83.4K. The position accounts for 0.02% of the portfolio, ranked #268.

Financial Perspectives first reported a position in TMDX in Q2 2021 and has held it in 13 quarters since. The position peaked at $395K in Q2 2023. 217 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Financial Perspectives held 1,000 shares of Transmedics worth $83.4K as of Q3 2026.
  • Financial Perspectives left its Transmedics share count unchanged in Q3 2026.
  • Transmedics made up 0.02% of Financial Perspectives's portfolio in Q3 2026, its #268 holding.
  • Financial Perspectives first reported a position in Transmedics in Q2 2021 and has held it in 13 quarters since.
  • Financial Perspectives's Transmedics position peaked at $395K in Q2 2023.
  • 217 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Financial Perspectives's 13F filing for Q3 2026, filed 3 Nov 2026.